Wikidata

(Q46626071)

English

The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.

scientific article published in May 2005

In more languages

Statements

title
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16053664
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16053664%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46626071&oldid=1561378509"